Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melphalan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03276481
What this trial is testing

Prospective Evaluation of Taste Function In Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 47
Testing effectiveness (Phase 2)WithdrawnNCT00085345
What this trial is testing

Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Stage II Multiple MyelomaStage III Multiple MyelomaRefractory Plasma Cell Neoplasm
Oncotherapeutics
Early research (Phase 1)Study completedNCT00002977
What this trial is testing

Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission

Who this might be right for
Ovarian Cancer
Fred Hutchinson Cancer Center 45
Large-scale testing (Phase 3)Study completedNCT00111319
What this trial is testing

VELCADE/Melphalan/Prednisone Versus Melphalan/Prednisone in Patients With Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)WithdrawnNCT02701673
What this trial is testing

Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00067002
What this trial is testing

Randomized Double Cord Blood Transplant Study

Who this might be right for
Leukemia, Lymphocytic, AcuteLeukemia, Myelocytic, AcuteLeukemia, Myeloid, Chronic+1 more
M.D. Anderson Cancer Center 110
Testing effectiveness (Phase 2)Study completedNCT00427557
What this trial is testing

Cellular Therapy With Cord Blood Cells

Who this might be right for
Multiple MyelomaLeukemiaLymphoma
M.D. Anderson Cancer Center 31
Early research (Phase 1)Active Not RecruitingNCT03352765
What this trial is testing

A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT01296256
What this trial is testing

Bendamustine, Cytarabine, Etoposide and Melphalan (BeEAM) as Conditioning for Autologous Stem Cell Transplant (ASCT) in Aggressive Non Hodgkin's Lymphoma (NHL).

Who this might be right for
BendamustineConditioning TherapyAutologous Stem Cell Transplant+1 more
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 60
Testing effectiveness (Phase 2)Looking for participantsNCT04332874
What this trial is testing

Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg

Who this might be right for
SarcomaMyxofibrosarcomaUndifferentiated Pleomorphic Sarcoma+1 more
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06001385
What this trial is testing

HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemia+8 more
Center for International Blood and Marrow Transplant Research 313
Large-scale testing (Phase 3)Study completedNCT01090089
What this trial is testing

Combination of Lenalidomide and Dexamethasone in Treatment of Multiple Myeloma

Who this might be right for
Multiple Myeloma
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 348
Testing effectiveness (Phase 2)Study completedNCT00358020
What this trial is testing

Melphalan, Prednisone, Thalidomide And Bortezomib In Advanced And Refractory Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
University of Turin, Italy 30
Testing effectiveness (Phase 2)Study completedNCT00325416
What this trial is testing

Study of Melphalan and Topotecan (MT) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma.

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 177
Large-scale testing (Phase 3)Study completedNCT01093196
What this trial is testing

Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 660
Not applicableNot Yet RecruitingNCT07542418
What this trial is testing

Study of Thiotepa Combination With Melphalan (TM Protocol) Conditioning for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma：A Prospective Randomized Controlled Clinical Trial

Who this might be right for
Multiple Myeloma
First Affiliated Hospital Xi'an Jiaotong University 204
Testing effectiveness (Phase 2)WithdrawnNCT00968396
What this trial is testing

Ex-Vivo Depletion of Myeloma Cells From Peripheral Blood Progenitor Cell Grafts

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT02043847
What this trial is testing

TMI With HD Mel in ASCT for R/R Multiple Myeloma (BMT-03)

Who this might be right for
Multiple Myeloma, RelapsedMultiple Myeloma, Refractory to Standard Treatment
University of Illinois at Chicago 12
Not applicableStudy completedNCT02082886
What this trial is testing

HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis - Data Registry

Who this might be right for
Peritoneal NeoplasmsNeoplasm MetastasisAdenocarcinoma+1 more
Edward-Elmhurst Health System 193
Testing effectiveness (Phase 2)Study completedNCT00679367
What this trial is testing

Melphalan, Lenalidomide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma
Boston Medical Center 16
Next Page